11 reports

SAES WERE REPORTED FOR ONE IN ## PATIENTS IN THE PICLIDENOSON GROUP AND ONE IN ## PATIENTS IN THE PLACEBO GROUP (CAN-FITE BIOPHARMA, NCT##).

  • Biopharmaceutical
  • Australia
  • Demand
  • Forecast
  • Galapagos NV

Arthritis Care and Research; ##(##): ##-## SingHealth (2014).

  • Biopharmaceutical
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Galapagos NV

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Biopharmaceutical
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Galapagos NV

Arthritis Care and Research; ##(##): ##-## SingHealth (2014).

  • Biopharmaceutical
  • Monoclonal Antibody
  • Therapy
  • Market Size
  • Galapagos NV
  • KEY EVENTS IMPACTING SALES FOR RA IN THE US, 2015-2025
  • NOVEL BIOLOGICS AND SMALL MOLECULES ARE WELCOME ADDITIONS TO THE RA MARKET

IN JUNE 2016, CAN-FITE BIOPHARMA ANNOUNCED THAT IT HAD REACHED AN AGREEMENT WITH THE EMA FOR CF-##' S PHASE III TRIAL DESIGN (CAN-FITE BIOPHARMA; PRESS RELEASE; JUNE ##, 2016).

  • Biopharmaceutical
  • Biosimilar
  • Epidemiology
  • Forecast
  • Galapagos NV

DARWIN ## ##. ##. ##. ##. ##.

  • Biopharmaceutical
  • North America
  • United States
  • Demand
  • Galapagos NV
  • HANALL BIOPHARMA CO LTD
  • UVEITIS - PIPELINE BY GALAPAGOS NV, H2 2019

In May 2019, Tetra Bio-Pharma Inc acquired Panag Pharma Inc.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Product Initiative
  • Galapagos NV

In December 2007, MorphoSys and Novartis substantially extended their previous relationship and forged one of the most comprehensive strategic alliances in the discovery and development of biopharmaceuticals.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Therapy
  • Galapagos NV

+IN DECEMBER 2007, MORPHOSYS AND NOVARTIS SUBSTANTIALLY EXTENDED THEIR PREVIOUS RELATIONSHIP AND FORGED ONE OF THE MOST COMPREHENSIVE STRATEGIC ALLIANCES IN THE DISCOVERY AND DEVELOPMENT OF BIOPHARMACEUTICALS.

  • Biopharmaceutical
  • Immunotherapy
  • Musculoskeletal Disorder
  • Therapy
  • Galapagos NV
  • UVEITIS - PIPELINE BY GALAPAGOS NV, H1 2018

ENHANX BIOPHARMA INC (A JOINT VENTURE OF BBB THERAPEUTICS B. V.

  • Biopharmaceutical
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Galapagos NV

REVERAGEN BIOPHARMA, INC.

  • Biopharmaceutical
  • United States
  • Company
  • Product Initiative
  • Galapagos NV